A detailed history of Westside Investment Management, Inc. transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Westside Investment Management, Inc. holds 250 shares of IDNA stock, worth $5,707. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 350 28.57%
Holding current value
$5,707
Previous $8.09 Million 24.35%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$22.86 - $25.49 $2,286 - $2,549
-100 Reduced 28.57%
250 $6.12 Million
Q4 2022

Jan 31, 2023

SELL
$24.22 - $29.01 $16,954 - $20,307
-700 Reduced 66.67%
350 $2.51 Million
Q3 2022

Nov 09, 2022

BUY
$25.77 - $34.57 $18,039 - $24,199
700 Added 200.0%
1,050 $21.2 Million
Q4 2020

Jan 15, 2021

BUY
$37.93 - $50.1 $1,896 - $2,505
50 Added 16.67%
350 $16,000
Q2 2020

Jul 21, 2020

BUY
$25.51 - $39.04 $7,653 - $11,712
300 New
300 $11,000

Others Institutions Holding IDNA

About ISHARES TR GENOMICS IMMUNOLOGY


  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.